General
Preferred name
LEVOSULPIRIDE
Synonyms
(S)-(-)-Sulpiride ()
(-)-sulpiride ()
RV-12309 ()
S-(-)-Sulpiride ()
RV-12309,S-(-)-Sulpiride ()
Sulpiride l-form ()
Levopride ()
Levopraid ()
Levosulpirida ()
Sulpiride, (-)- ()
L-sulpiride ()
Lesuride ()
Levobren ()
Sulpiride, (s)- ()
P&D ID
PD002616
CAS
23672-07-3
Tags
available
drug
Drug Status
approved
investigational
Max Phase
2.0
Drug indication
Dyspepsia
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION The (-)-enantiomer of sulpiride is approved with the INN levosulpiride and is also a component of the approved drug . (GtoPdb)
PRICE 29
DESCRIPTION Levosulpiride (RV-12309) is the (S)-enantiomer of sulpiride, which is a D2 receptor a antagonist, an atypical antipsychotic agent of the benzamide class.
DESCRIPTION Levosulpiride is the (S)-enantiomer of sulpiride, which is a D2 receptor a antagonist. Levosulpiride is indicated to treat dyspepsia, symptoms of Meniere's syndrome, and second line in the treatment of drug-induced nausea and vomiting. (Enamine Bioactive Compounds)
DESCRIPTION Standard selective D2-like antagonist (Tocriscreen Plus)
DESCRIPTION D2 dopamine receptor antagonist; antipsychotic (LOPAC library)
DESCRIPTION Standard selective D2-like antagonist (Tocriscreen Total)
DESCRIPTION Selective P2Y1 antagonist (Tocris Bioactive Compound Library)
DESCRIPTION Levosulpiride (S-(-)-Sulpiride) is the (S)-enantiomer of sulpiride, which is a D2 receptor antagonist, an atypical antipsychotic drug of the benzamide class. (TargetMol Bioactive Compound Library)
Compound Sets
24
ChEMBL Drugs
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
Concise Guide to Pharmacology 2025/26
CZ-OPENSCREEN Bioactive Library
Drug Repurposing Hub
DrugBank
DrugCentral
DrugCentral Approved Drugs
Enamine Bioactive Compounds
EU-OPENSCREEN Bioactive Compound Library
Guide to Pharmacology
LOPAC library
LSP-MoA library (Laboratory of Systems Pharmacology)
MedChem Express Bioactive Compound Library
NIH Clinical Collections (NCC)
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
Tocris Bioactive Compound Library
Tocriscreen Plus
Tocriscreen Total
External IDs
95
Properties
(calculated by RDKit )
Molecular Weight
341.14
Hydrogen Bond Acceptors
5
Hydrogen Bond Donors
2
Rotatable Bonds
6
Ring Count
2
Aromatic Ring Count
1
cLogP
0.56
TPSA
101.73
Fraction CSP3
0.53
Chiral centers
1.0
Largest ring
6.0
QED
0.79
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target Type
7-TM Receptors
Selectivity
D2
Target
dopamine
CA1, CA12, CA7, DRD2, DRD3
Dopamine Receptor
5-HT Receptor
Primary Target
Non-selective Dopamine
MOA
Antagonist
Dopamine Receptor antagonist
Indication
schizophrenia, psychosis, anxiety, vertigo, dyspepsia, irritable bowel syndrome, premature ejaculation (PE)
Disease Area
neurology/psychiatry, gastroenterology, urology
Pathway
GPCR/G protein
Neuronal Signaling
Neuroscience
Source data